Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical (TSE:PREV)
:PREV
RESEARCH TOOLSreports
Total Valuation
PreveCeutical Medical has a market cap or net worth of C$16.25M. The enterprise value is C$12.35M.
Market CapC$16.25M
Enterprise ValueC$12.35M
Share Statistics
PreveCeutical Medical has 541,703,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding541,703,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PreveCeutical Medical’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 49.54%.
Return on Equity (ROE)0.22
Return on Assets (ROA)-7.02
Return on Invested Capital (ROIC)49.54%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee0.00
Profits Per Employee-182.07K
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PreveCeutical Medical is -10.50. PreveCeutical Medical’s PEG ratio is 0.74.
PE Ratio-10.50
PS Ratio―
PB Ratio-2.32
Price to Fair Value-2.32
Price to FCF-45.06
Price to Operating Cash Flow-45.06
PEG Ratio0.74
Income Statement
In the last 12 months, PreveCeutical Medical had revenue of 0.00 and earned -1.27M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-9.86K
Operating Income-963.12K
Pretax Income-1.27M
Net Income-1.27M
EBITDA-955.09K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -397.96K and capital expenditures -1.08K, giving a free cash flow of -399.04K billion.
Operating Cash Flow-397.96K
Free Cash Flow-399.04K
Free Cash Flow per Share>-0.01
Dividends & Yields
PreveCeutical Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change0.00%
50-Day Moving Average0.03
200-Day Moving Average0.02
Relative Strength Index (RSI)55.22
Average Volume (3m)269.79K
Important Dates
PreveCeutical Medical upcoming earnings date is Apr 30, 2025, TBA Not Confirmed.
Last Earnings DateNov 21, 2024
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
PreveCeutical Medical as a current ratio of 0.01, with Debt / Equity ratio of -68.43%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap0.29
Net Debt to EBITDA-4.01
Interest Coverage Ratio-3.11
Taxes
In the past 12 months, PreveCeutical Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PreveCeutical Medical EV to EBITDA ratio is -18.02, with an EV/FCF ratio of -57.97.
EV to Sales0.00
EV to EBITDA-18.02
EV to Free Cash Flow-57.97
EV to Operating Cash Flow-57.97
Balance Sheet
PreveCeutical Medical has C$236.00 in cash and marketable securities with C$4.49M in debt, giving a net cash position of C$4.30M billion.
Cash & Marketable SecuritiesC$236.00
Total DebtC$4.49M
Net CashC$4.30M
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PreveCeutical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-150.00%